Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Guillain-Barre Syndrome (GBS)”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Early research (Phase 1)Study completedNCT01052935
What this trial is testing

Assess the Persistence of a GBS Antibody in Women Previously Immunized With a GBS Vaccine

Who this might be right for
Group B Streptococcus (GBS) Disease
Novartis 50
Not applicableUnknownNCT02582853
What this trial is testing

SCD163 as a Potential Biomarker in Guillain- Barré Syndrome

Who this might be right for
Guillain-Barre Syndrome
University of Aarhus 60
Not applicableUnknownNCT04166357
What this trial is testing

Early Prediction of Respiratory and Autonomic Complications of GBS Using Neuromuscular Ultrasound

Who this might be right for
Guillain Barre Syndrome
Mansoura University Hospital 100
Early research (Phase 1)Study completedNCT01053767
What this trial is testing

Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS Vaccine

Who this might be right for
Group B Streptococcus (GBS) Disease
Novartis Vaccines 95
Not applicableStudy completedNCT01445717
What this trial is testing

Rapid Diagnostic Test for Detection of Group B Streptococcus in Pregnancy

Who this might be right for
Streptococcus InfectionPregnancy
The University of Texas Health Science Center, Houston 358
Not applicableNot Yet RecruitingNCT06996509
What this trial is testing

Noninvasive Support for Acute Respiratory Failure in Guillain-Barré Syndrome

Who this might be right for
Guillain-Barre Syndrome
Assiut University 80
Early research (Phase 1)Study completedNCT00645346
What this trial is testing

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of Age

Who this might be right for
Invasive Group B Streptococcus (GBS) Disease
Novartis Vaccines 130
Testing effectiveness (Phase 2)Study completedNCT02493725
What this trial is testing

JET-GBS - Japanese Eculizumab Trial for GBS

Who this might be right for
Gullain Barre Syndrome
Chiba University 34
Not applicableStudy completedNCT00575653
What this trial is testing

Safety Study of GBS Following Menactra Meningococcal Vaccination

Who this might be right for
Guillain-Barre Syndrome
Harvard Pilgrim Health Care 6,000,000
Large-scale testing (Phase 3)WithdrawnNCT05494619
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS)

Who this might be right for
Guillain-Barré Syndrome
Hoffmann-La Roche
Not applicableNot Yet RecruitingNCT06896526
What this trial is testing

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

Who this might be right for
Invasive Group B Streptococcus DiseaseGroup B StreptococcusGroup B Streptococcal Infection+3 more
Precia Group 10,000
Large-scale testing (Phase 3)Looking for participantsNCT07020819
What this trial is testing

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

Who this might be right for
Guillain-Barre Syndrome
Annexon, Inc. 30
Not applicableLooking for participantsNCT05212792
What this trial is testing

Genomics and COVID-19 Vaccine Adverse Events

Who this might be right for
Vaccine Adverse Reaction
University of British Columbia 6,325
Not applicableLooking for participantsNCT06940908
What this trial is testing

Living With Guillain-Barré Syndrome as Children.

Who this might be right for
Guillain Barré SyndromeGuillain-Barré Syndrome (GBS)
University Hospital, Toulouse 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT06885762
What this trial is testing

Efgartigimod for the Treatment of Guillain-Barré Syndrome

Who this might be right for
Guillain-Barre Syndrome (GBS)
Zhongming Qiu 20
Not applicableStudy completedNCT01306578
What this trial is testing

Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)

Who this might be right for
Guillain Barre Syndrome
Mansoura University Children Hospital 41
Not applicableLooking for participantsNCT06615622
What this trial is testing

Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes.

Who this might be right for
Guillain Barré SyndromeChronic Inflammatory Demyelinating PolyradiculoneuropathyPeripheral Nerve Disorder+2 more
Assiut University 90
Testing effectiveness (Phase 2)Study completedNCT00056810
What this trial is testing

Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine

Who this might be right for
Guillain-Barre Syndrome
FDA Office of Orphan Products Development 30
Testing effectiveness (Phase 2)Study completedNCT03943589
What this trial is testing

Imlifidase in Patients With Guillain-Barré Syndrome

Who this might be right for
Guillain-Barré Syndrome (GBS)
Hansa Biopharma AB 30
Early research (Phase 1)WithdrawnNCT03773328
What this trial is testing

A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS)

Who this might be right for
Guillain-Barré Syndrome
Cellenkos, Inc.
Load More Results